# Maternal supplementation of vitamin B12 in predominantly vegetarian pregnant women improves their vitamin B12 status and the neurodevelopment of their infants: the MATCOBIND multicentric double-blind randomised control trial

**Authors:** Jitender Nagpal, Manu Mathur, Swapnil Rawat, Atul Singhal, Rajendra Pant, Anita Shah, Laura Nixon, Vijay Kumar Mishra, Deepti Nagrath, Michelle Heys, Mario Cortina-Borja, Colin Michie, Jageshwor Gautam, Shailendra Bir Karmacharya, Snighda Rai, Monica Lakhanpaul

PMC · DOI: 10.1136/bmjpo-2025-004112 · BMJ Paediatrics Open · 2026-03-18

## TL;DR

Giving higher vitamin B12 doses to vegetarian pregnant women improves their B12 levels and boosts infant mental development.

## Contribution

Demonstrates that 250 µg B12 supplementation in vegetarian pregnant women improves infant neurodevelopment more than 50 µg.

## Key findings

- Infants of mothers receiving 250 µg B12 had higher mental developmental quotients (DQs) compared to those receiving 50 µg.
- Maternal vitamin B12 levels increased more significantly in the 250 µg group than in the 50 µg group.
- Infant B12 levels were within normal ranges, and no adverse effects were observed in either group.

## Abstract

Vitamin B12 deficiency is common in populations with limited animal-source foods and has been linked to delayed infant neurodevelopment and adverse pregnancy outcomes. Evidence on the benefits of maternal B12 supplementation for improving infant neurodevelopment remains mixed, particularly in low-income and middle-income countries where deficiency is prevalent.

This double-blind, randomised controlled trial was conducted in two tertiary maternity care centres in India and Nepal. Pregnant women in their first trimester, following a vegetarian diet, were enrolled and randomised to receive either a daily oral supplement of 250 µg (group A) or 50 µg (group B) of methyl-cobalamin from enrolment to 6 months post partum. The primary outcomes were infant neurodevelopment assessed at 9–12 months using the Development Assessment Scale of Indian Infants and biochemical B12 status in mothers and infants measured through blood tests.

531 mothers completed the study (group A n=255; group B n=276). There were no significant differences in baseline characteristics between mothers at both centres or in groups A and B. Mental developmental quotients (DQs) were higher in the infants of group A: 103.7 (7.7) than group B: 101.7 (8.8); p=0.008). This corresponds to a mean difference of 7.8 centiles (p=0.007). Mean motor DQs were not significantly different between the groups. Maternal vitamin B12 levels rose from the first to third trimester in both groups, with a larger increase in group A (104.9 pg/mL (SD 159.1)) than group B (47.5 pg/mL (SD 118.0)), p<0.001. Holotranscobalamin levels improved similarly (p<0.001). All infant levels of vitamin B12 were within the normal range. Newborn anthropometry, APGAR scores and morbidity profiles were similar in both groups (p>0.05). Serum ferritin, vitamin D and folate were similar (p>0.05).

Daily supplementation with 250 µg of vitamin B12 during pregnancy in vegetarian mothers significantly improved infant mental DQ and maternal B12 status compared with a 50 µg dose.

## Linked entities

- **Chemicals:** vitamin B12 (PubChem CID 73415824), methyl-cobalamin (PubChem CID 6436232)

## Full-text entities

- **Genes:** PSIP1 (PC4 and SRSF1 interacting protein 1) [NCBI Gene 11168] {aka DFS70, LEDGF, PAIP, PSIP2, p52, p75}, TPPP (tubulin polymerization promoting protein) [NCBI Gene 11076] {aka TPPP/p25, TPPP1, p24, p25, p25alpha}
- **Diseases:** congenital hypothyroidism (MESH:D003409), biotinidase deficiency (MESH:D028921), impaired cobalamin function (MESH:C564747), hearing deficits (MESH:D006311), Biochemical deficiencies (MESH:D007153), diabetes (MESH:D003920), TC Deficiency (OMIM:275350), miscarriages (MESH:D000022), drug/alcohol abuse (MESH:D019966), B12 insufficiency (MESH:D000309), depression (MESH:D003866), Death (MESH:D003643), hypothyroidism (MESH:D007037), neonatal deaths (MESH:D066087), congenital adrenal hyperplasia (MESH:D000312), heart, neurological (MESH:D006331), preterm delivery (MESH:D047928), B12 (MESH:D014806), Hypovitaminosis D (MESH:D014808), Anaemia (MESH:D000743), congenital malformation (OMIM:163000), hepatitis B (MESH:D006509), HIV (MESH:D015658), Folate Deficiency (MESH:C562799), Neonatal jaundice (MESH:D007567), gestational diabetes (MESH:D016640), growth retardation (MESH:D006130), seizures (MESH:D012640), congenital abnormalities (MESH:D000013), DQ (MESH:C567924), COVID-19 (MESH:D000086382), iron deficiency (MESH:D000090463), rickets (MESH:D012279), congenital heart disease (MESH:D006330), phenylketonuria (MESH:D010661), hypertension (MESH:D006973), hypothermia (MESH:D007035), growth restriction (MESH:D005317), neurological problems (MESH:D009461), PMWH (MESH:D003428), cystic fibrosis (MESH:D003550), neural tube defects (MESH:D009436), Extreme prematurity (MESH:C536271), syphilis (MESH:D013587), Metabolic disorders (MESH:D008659), thyroid disease (MESH:D013959), gastrointestinal symptoms (MESH:D012817), mental health disorder (OMIM:603663)
- **Chemicals:** EDTA (MESH:D004492), iron (MESH:D007501), methyl-cobalamin (MESH:C019476), Holo (-), B12 (MESH:C034730), Homocysteine (MESH:D006710), vitamin D (MESH:D014807), Vitamin B12 (MESH:D014805), TC (MESH:D013667), Folate (MESH:D005492)
- **Species:** Gallus gallus (bantam, species) [taxon 9031], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** 677C>T

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13034390/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC13034390/full.md

## References

37 references — full list in the complete paper: https://tomesphere.com/paper/PMC13034390/full.md

---
Source: https://tomesphere.com/paper/PMC13034390